The LIPID MAPS meeting features two poster sessions with 66 posters. Of these, twelve were selected for lightning talks (see program) by the review committee, Susan A. Henry, David W. Russell, and Sarah Spiegel. We received so many high quality, relevant abstracts that making these selections was difficult. The poster presenters are also cross referenced in the attendee list.
Effect of imatinib on nitrite levels in LPS/
Imatinib is a tyrosine-kinase inhibitor used in the treatment of different cancers and inhibits BCR-ABL oncoprotein which is the product of the Philadelphia chromosome fusion gene in chronic myeloid leukemia. It is reported that imatinib treatment may have the potential to inhibit various inflammatory markers. Therefore in this study, we investigated the effect of imatinib on nitric oxide production and viability in LPS-IFNγ stimulated RAW 264.7 macrophage cells. For this purpose, cells were incubated with various concentrations of imatinib(0,125-50 M) for 1 hour and then stimulated with LPS-IFNγ for 20 h. Nitrite levels were determined with griess reaction and cell viability was determined with MTT assay. Our results showed that imatinib pretreatment of RAW 264.7 macrophage cells before stimulation with LPS/IFN gamma didn't suppress nitric oxide production and iNOS protein levels. The effects of imatinib on different inflammatory markers in this cell model can be analysed for further studies. Lysophospholipids (LPLs) serve as important lipid mediators and also as precursors for synthesis of diacyl phospholipids (PLs). LPLs detected in cells have various acyl chains attached at either the sn-1 or sn-2 position of the glycerol backbone. In general acyl chains at the sn-2 position of 2-acyl-1-lyso-PLs readily move to the sn-1 position, generating 1-acyl-2-lyso isomers by non-enzymatic reaction called intra-molecular acyl migration, which has hampered the detection of 2-acyl-1-lyso-PLs in biological samples. In this study, we developed a simple and versatile method to separate and quantify 2-acyl-1-and 1-acyl-2-lyso-PLs in a condition that completely eliminated the intra-molecular acyl migration. We found that the acyl migration reaction was dependent on both temperature and pH of the solvent. At pH 4 and 4°C, the ratio of 2-acyl-1-lyso-and 1-acyl-2-lyso-LPLs including lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylinositol, lysophosphatidylserine, lysophosphatidylglycerol and lysophosphatidic acid, which was prepared by either phospholipase A 1 or A 2 reaction, respectively, did not change at least for 1 week. By contrast at neutral pH or basic buffer (pH 9), all these 2-acyl-1-lyso isomers were quickly converted to the corresponding 1-acyl-2-lyso isomers. When LPLs were extracted from various mouse tissues at pH 4, most of the saturated fatty acid (16:0 and 18:0)-containing LPLs were found to be 1-acyl-2-lyso isomers, while most of the polyunsatulated fatty acid (18:2, 20:4, 22:6)-containing LPLs were 2-acyl-1-lyso isomers. Distribution of oleic acid (18:1) in LPLs of the sn-1 and sn-2 position differed among tissues. When extracted in neutral condition, the uneven distributions of acyl chains were completely lost. We further showed that cells treated with phosphatidylserine (PS)-specific phospholipase A 1 contained 2-acyl-1-lyso-LysoPS, suggesting that 2-acyl-1-lyso-LPLs are stable on the cell membrane. On the other hand, LysoPS extracted from the cells by albumin was converted into 1-acyl-2-lysoPS, indicating that albumin accelerated the acyl migration reaction. The present method is definitely useful for elucidating in vivo role of 2-acyl-1-lyso-PLs.
Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS

For all poster abstracts:
Presenting author is underlined # Background: Fatty liver dystrophy (fld) mice are metabolically well characterized. They have reduced white and brown fat pads, hyperglycemia, hyperinsulinemia, and diet-related atherosclerosis. The factor responsible for this phenotype is a mutation in the Lpin-1 gene, which encodes for Lipin-1, a Mg 2+ -dependent phosphatidic acid phosphatase (PAP) involved in the de novo synthesis of phospholipids and triacylglycerol. Previous work in our laboratory has shown that this enzyme plays a role in macrophage biology by regulating the size and amount of lipid droplets, and also by regulating the activation of group IVA phospholipase A 2 and prostaglandin production.
Objective:
To study the impact of lipin-1 on TLR-4-mediated signaling and inflammatory responses of macrophages.
Methods:
Adult fld and wild type (wt) mice were sacrificed, peritoneal macrophages and bone-marrow were isolated, and incubated with 100ng/ml LPS. Measurement of mRNA levels, protein expression, cytokine release and lipid levels were conducted.
Results: Bone marrow and peritoneal macrophages from fld mice exhibit more moderate iNOS and COX-2 increases and IL-6, IL-12 and IL-23 cytokine generation after TLR-4 activation compared to wild type cells. This restrained response is due to a lower phosphorylation of mitogen-activated protein kinases (MAPK), which leads to reduced activation of the AP-1 transcription factor and, consequently, to lower levels of pro-inflammatory proteins. Contrary to wild type cells, diacylglycerol levels in fld macrophages decreases after LPS stimulation, which presumably accounts for the reduced MAPK activation.
Conclusion:
Fatty liver dystrophy restrains the inflammatory response of macrophages due to alterations in lipid metabolism.
Synthesis of analogs of myo-inositol to enable chemical biology studies
Tanei Ricks, Michael D. Best University of Tennessee-Knoxville, Knoxville, TN.
Myo-inositol is an important biological molecule that plays a role in a variety of cellular signaling processes and acts as the biosynthetic precursor to a number of other key biomolecules. Great work has been put into synthesizing naturally occurring products of myo-inositol, such as the phosphatidylinositolpolyphosphates (PIPs), as well as numerous analogs thereof for use as probes. Prior research has shown that the C-2 and C-6 positions of myo-inositol are the least modified positions intercellularly, which suggests greater ability for functionalization while maintaining biological function. Here, we will describe progress towards the design and synthesis of various azide-functionalized myo-inositol derivatives as well as potential applications for these derivatives in studying cellular signaling events.
Integration of lipidomic data and computational modeling for studying sphingolipid metabolism in macrophages
Nathan Chiappa, Edward Botchwey Georgia Institute of Technology, Atlanta, GA.
The advent of high-throughput lipidomic technology has allowed for the generation of vast amounts of information on the lipidomic state of a cell. However, this information can be difficult to interpret given the size of the data sets and the complexity of the underlying metabolic network. Computational modeling is a powerful tool for integrating and interpreting these data. We have constructed for the first time a computational model of sphingolipid metabolism in RAW264.7 macrophages that accounts for all of the sphingolipid species measured in the 2010 LIPID MAPS mouse macrophage lipidome study. Two variants of the model were constructed using the traditional Michaelis-Menten formalism as well as the Biochemical Systems Theory formalism for comparison. The model contains 57 lipids connected by 121 reactions. All model parameters were obtained from an extensive literature search.
The model is locally stable and returned to steady-state following small perturbations to lipid concentrations. Additionally, the model exhibited small sensitivities to changes in parameter values. Both of these indicate that the model is robust. Additionally we validated the model against the dynamic time-series data for each sphingolipid available on the LIPID MAPS database. The model showed good agreement with the experimental data suggesting that the model is a good representation of the metabolic network.
This model represents a powerful tool for understanding and predicting the behavior of sphingolipid metabolism in response to a wide array of perturbations. The systemic response to transient and sustained changes in enzyme activity as seen during inflammation can readily be investigated. Additionally, the systemic response to various sphingolipid enzyme-modulating drugs can be determined. Thus, this model can help advance our understanding of the sphingolipid metabolic network as an integrated whole as well as allow for optimization of therapeutic intervention into sphingolipid-mediated pathologies.
Fatty acid heme dioxygenase and catalase-related hydroperoxide lyase cooperate in linoleate metabolism in Nostoc punctiforme
Alan R. Brash, Narayan P. Niraula, William E. Boeglin, Zahra Mashhadi Department of Pharmacology and the Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN.
In the course of exploring the scope of catalase-related hemoproteins' reactivity towards fatty acid hydroperoxides, we detected a novel candidate in the cyanobacterium Nostoc punctiforme PCC 73102. The immediate neighboring upstream gene, annotated as "cyclooxygenase-2", appeared to be a potential fatty acid heme dioxygenase. We cloned both genes and expressed the cDNAs in E. coli, confirming their hemoprotein character. Oxygen electrode recordings demonstrated a rapid (>100 turnovers/s) reaction of the heme dioxygenase with oleic and linoleic acids. HPLC including chiral column analysis, UV, and GC-MS of the oxygenated products identified a novel 10S-dioxygenase activity. The catalase-related hemoprotein reacted rapidly and specifically with linoleate 10S-hydroperoxide (> 2,500 turnovers/s) with a hydroperoxide lyase activity specific for the 10S-hydroperoxy enantiomer. The products were identified by NMR as (8E) 10-oxodecenoic acid and the C8 fragments, 1-octen-3-ol and 2Z-octen-1-ol in ~ 3:1 ratio. Chiral HPLC analysis established strict enzymatic control in formation of the 3R alcohol configuration (99% ee) and contrasted with racemic 1-octen-3-ol formed in reaction of linoleate 10S-hydroperoxide with hematin or ferrous ions. The Nostoc linoleate 10S-dioxygenase, the sequence of which contains the signature catalytic sequence of cyclooxygenases and fungal linoleate dioxygenases (YRWH) appears to be a heme dioxygenase ancestor. The novel activity of the lyase expands the known reactions of catalase-related proteins and functions in Nostoc in specific transformation of the 10S-hydroperoxylinoleate and suggests that related enzymes may be harbored in other bacterial genomes. Supported by NIH grant GM-74888.
Calorie restriction increases insulin sensitivity in skeletal muscle through sphingolipid metabolism
Diana Obanda, Yongmei Yu, Zhong Wang, William Cefalu Pennington Biomedical Research Center, Baton Rouge, LA.
The sphingolipid pathway exerts control over insulin signaling in insulin sensitive tissues. An improvement in insulin sensitivity is one of the most consistent features of calorie restriction (CR) as observed in rodent, primate and human models. The cellular mechanism(s) by which CR enhances insulin action are not precisely known. We sought to examine the effect of calorie restriction on sphingolipid metabolism in relation to insulin sensitivity in skeletal muscle of rats over 6 months. At baseline, male Fischer-344 rats (n=29) were randomized to an ad libitum (AL) diet or to 30% CR. Dietary intake, body weight, and insulin sensitivity were monitored routinely. At the end of the study, skeletal muscle (vastus lateralis) was obtained in the basal and insulin-stimulated states for insulin signaling and sphingolipid profiling.Compared to the AL diet, CR significantly increased whole-body insulin-mediated glucose disposal and significantly lowered the index of homeostasis model assessment of insulin resistance (HOMA-IR) (p<0.05; n=29). Western blotting showed that Akt 2 and IRS protein abundance and Akt phosphorylation in skeletal muscle was significantly upregulated in CR animals (p<0.05; n=29). CR altered the expression of proteins involved in sphingolipid formation and metabolism. CR significantly downregulated the expression of glucosylceramide synthase, lactosylceramide synthase and GM3 synthase, enzymes involved in glycosphingolipid formation (p<0.05; n=29). Quantification of metabolically stable sphingolipids showed that the quantities of ceramides were increased in CR while hexosylceramides and lactosylceramides were significantly lowered in CR (p<0.01; n=29). Ceramide phosphates, sphingomyelins, sphingosine and sphingosine phosphate were not significantly different between AL and CR groups. Lactosylceramide quantities correlated significantly with insulin resistance (HOMA-IR (R=0.72; p<0.005).We concluded that the increase in insulin sensitivity in CR is associated with modulation of proteins involved in sphingolipid formation and metabolism. While ceramides unexpectedly increased in CR, glycosphingolipids: hexosylceramides and lactosylceramides were significantly reduced in calorie restriction. The final stage of cholesterol biosynthesis involves the conversion of lanosterol to cholesterol. Two alternative pathways, known as the Bloch and Kandutsch-Russell (K-R) pathways, have been proposed for this conversion. To assess the relative utilization of these pathways by different tissues we used LC-MS/MS methods developed by the Lipid MAPS consortium, deuterium water (D 2 O) incorporation, and isotopic spectral analysis to measure flux of post-squalene cholesterol biosynthetic intermediates in cultured cells and mouse tissues. Flux through the Bloch pathway relative to the K-R pathway differed substantially among different cultured cell lines, ranging from >95 % in mouse adrenal cells (Y1-BS1), 60% in human liver cells (HuH7 cells) to < 10% in human skin fibroblasts (SV-589). We did not find any cell type in which the K-R pathway, as it was originally described, was operative. The initial K-R pathway intermediates (dihydrolanosterol, dihydro-ff-MAS, and dihydro-t-MAS) were present but did not turnover. Moreover, cholesterol biosynthesis proceeded through a hybrid pathway: lanosterolzymosterol 24-25 side chain double bond desaturated7-dehydrocholesterol cholesterol. To determine if the patterns of pathway utilization in the cell lines reflected the tissues of origin in vivo, we performed labeling studies using D 2 O in 12-week old male mice. The Bloch pathway predominated in adrenals, spleen and testes, whereas the hybrid pathway was preferentially used in skin, brain and preputial glands. The liver and kidney were intermediate between these extremes. Thus, the cholesterol biosynthetic pathways utilized by cultured cells mirror those used by the tissue from which they are derived and a hybrid pathway between the Bloch and K-R pathway appears to be the alternative pathway to the Bloch pathway. There is no fully distinct alternative to the Bloch pathway as originally proposed. N-acyl phospholipids are minor components of membrane lipids and potential precursors of lipid mediators such as anandamide. Here, we show that ABHD4, a member of serine hydrolase superfamily, regulates metabolic pathways of multiple N-acyl phospholipids in the mammalian central nervous systems. Brains from Abhd4 -/-mice exhibited the significant decreases in the levels of glycerophospho-NAEs (GP-NAEs) and N-acyl lysophosphatidylethanolamines (lysoNAPEs). Moreover, N-acyl lyso ethanolamine plasmalogens (lyso pNAPEs) were remarkably decreased in Abhd4 -/-brains. Interestingly, an untargeted metabolomics approach revealed that N-acyl lysophosphatidylserines (lysoNAPSs), a hitherto unidentified novel class of lipid, were dramatically decreased in brains from Abhd4 -/-mice. Enzyme assays confirmed that N-acyl ethanolamine plasmalogen (pNAPE) and N-acyl phosphatidylserine (NAPS) are direct substrates of ABHD4. Together, our study indicates that ABHD4 is a key enzyme for the degradation of both glycerophospho-N-acyl ethanolamine and glycerophospho-N-acyl serine lipids. Endocannabinoids activate the cannabinoid receptors and produce similar psychoactive effects to Cannabis. Anandamide (AEA) and 2 -arachidonoylglycerol (2-AG) are the two most characterized endocannabinoids. Herein we demonstrate the direct metabolism of 2-AG and AEA by human heart CYP2J2 epoxygenase. CYP2J2 synthesizes epoxyeicosatrienoic acids (EET) from arachidonic acid (AA) that are implicated in inflammation, cardiovascular disease and cancer. In this work, we elucidate the nuances of ligand-protein interactions using spectral titrations, small molecule ligand egress, molecular modeling and LC-MS. We use Nanodiscs (nanoscale lipid bilayers) to solubilize and stabilize membrane bound CYP2J2 for these studies. The binding study shows that simply by changing the residue at the carboxylic acid end of AA to ester (in 2-AG) or amide (in AEA) changes the binding interaction of these lipids with CYP2J2 active site. Furthermore molecular modeling confirmed that this carboxylic acid site indeed plays an important role in docking of the substrate molecule to the active site. We further studied the metabolism and kinetics of product formation using LC-MS. Reactions of CYP2J2 with AEA formed four AEA-epoxide products (EET-EA). Interestingly, incubations of 2-AG with CYP2J2 yielded detectable levels of only two 2-AG epoxides (2EG) as shown to be present in tissues samples from kidney and spleen. The incubation of CYP2J2 with 2-AG also produces considerable amount of free AA, glycerol and EETs in solution, that are products of oxidative ester hydrolysis of 2-AG. This shows that CYP2J2 not only metabolizes 2-AG but also provides an alternative pathway for its hydrolysis. In summary, we successfully identified a cardiovascular CYP that binds and metabolizes both AEA and 2-AG as well as oxidatively cleaves the 2-AG ester, effectively attenuating 2-AG activity. Our investigation of the interactions of the lipids with CYP2J2 suggests potential cross talk between the endocannabinoind metabolism and lipid metabolism pathways in the heart.
Elucidating
We have developed and optimized protocols for separating phospholipid and sphingolipid classes from a phospholipid mixture and human serum using Hydrophilic Interaction Liquid Chromatography (HILIC), Reversed Phase (RP) Chromatography, and Differential Ion Mobility Spectrometry (DMS). This exploration was carried out on an AB SCIEC 6500 QTRAP (MS) equipped with an AB SCIEX Selexion DMS and Waters Acquity Ultra Performance liquid Chromatography (UPLC). Besides optimizing each approach separately, we also explored advantages of combining HILIC-UPLC with DMS as well as RP-UPLC with DMS and new results will be described and discussed. The nuclear lamina is a mesh-like layer of type V intermediate filaments that is tightly associated to the inner nuclear membrane and is required for the proper function of the cell. A well-known function is the provision of structural scaffolding for the cell nucleus, however it also plays an important role in regulation of gene transcription, cell-cycle progression, DNA-damage response, nuclear envelope breakdown and nuclear pore complex organization as well as other functions. The main protein isoforms constituting the nuclear lamina are lamins A, C, B1, B2 and B3. Post-transcriptional phosphorylation of lamin proteins on either serine or threonine sites have been shown to cause turnover of the protein. Gerarduzzi et al. performed phosphoproteomic analysis (phosphopeptide enrichment by affinity chromatography, LC-MS/MS phosphopeptide analysis (LTQ-Obitrap-CID), and SEQUEST bioinformatics analysis of spectra) of GPCR activated (prostaglandin E2 stimulation) human fibroblast cells. This study revealed PGE2/GPCR/PKA phosphosubstrates, one of which was a heavily phosphorylated (> 10 fold over control: control, 1.09 x 10 6 vs ligand, 13 x 10 6 , relative peak intensities; p < 0.0001) peptide containing phosphothreonine (T)10 of lamin A. To study the function of this phosphorylation site, we developed rabbit polyclonal antibodies against the 20-mer N-terminal region of the wild-type and phosphoT-10 peptides as well as GFP-lamin A (wt and T10->A10; T10->E10 mutations) fusion expression plasmids. Subsequent analysis involved immunoprecipitation, western blot, transfection and confocal microscopy, disclosed that phosphorylation of T10 maybe a signal for lamin A disassembly from the nuclear lamina leading to its degradation.
Untargeted metabolomics of human ex-plant lung associated with cystic fibrosis
Neha Garg, Yan Wei Lim, Douglas Conrad, Forest Rohwer, Pieter C. Dorrestein Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA.
Direct measurement of metabolites from diseased tissue remains a challenge owing to structural diversity of the large number of primary and secondary metabolites present. These metabolites represent the climax of all physiological responses and reflect ecological relationships between pathogenic microbes and human response. Strategies aiming at direct measurement of metabolites will enhance our understanding of the roles that these molecules play and may result in emergence of new molecules and novel biosynthetic pathways. Untargeted metabolomics employed for such studies generates large volume of datasets that are rich in information hampering comprehensive analysis. Recent advancements in mass spectrometry and bioinformatics tools have reinvigorated the field of untargeted metabolomics of complex samples. Herein, we employ highscan-speed QTOF coupled with ultra high performance liquid chromatography for data collection combined with molecular networking as organizational tool, cytoscape as visualization tool, and automated database search for rapid identification of metabolites present in a human lung. A suite of bioactive lipids, sterols, fatty acids, and drugs were identified from direct tissue extractions of ex-plant human lung associated with cystic fibrosis. Disorders of cholesterol metabolism contribute significantly to the burden of human disease. Smith-Lemli-Opitz Syndrome (SLOS) is a rare disorder caused by a defect in cholesterol biosynthesis that presents in infancy with multiple developmental abnormalities. SLOS results from mutation of 7-dehydrocholesterol reductase (DHCR7), the gene encoding the final enzyme in the Kandutsch-Russell cholesterol biosynthetic pathway. This results in reduced cholesterol and a coordinate increase in the precursor, 7-dehydrocholesterol. Lipid rafts are cholesterol-enriched membrane microdomains that serve as signaling platforms in multiple prototypical pathways, including that of the Toll like Receptors (TLRs). Raft-dependent signaling is sensitive to raft cholesterol levels. We hypothesized that SLOS cells would display abnormal TLR signaling, thus offering a unique opportunity to define the importance of endogenous cholesterol biosynthesis to the innate immune response. Primary dermal fibroblast lines from SLOS patients were confirmed for the SLOS metabolic phenotype by GC/MS. The SLOS fibroblasts produced significantly lower IL-6 and IL-8 in response to lipopolysaccharide (LPS) stimulation compared to controls. Intriguingly, an inverse correlation was observed between clinical SLOS severity scores of the source patients and IL-6 response to LPS, and a direct correlation between residual DHCR7 enzyme activity and IL-6 production. Further, SLOS cells displayed a decrease in NFkB p65 activation upon LPS stimulation in comparison with WT controls. Using DHCR7 inhibitors on primary human macrophages to recapitulate the SLOS phenotype, preliminary studies indicate that TNFα production is attenuated in response to LPS stimulation compared to vehicle controls. Taken together, these findings indicate that the SLOS mutation confers abnormal innate immune responses. The correlation between clinical severity and LPS responsiveness of SLOS cells may suggest a clinically relevant role for altered innate immunity in SLOS. Understanding mechanisms by which cholesterol impacts innate immune function may provide novel insight into pathogenesis and therapy of a wide range of immune-mediated diseases. Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY.
Smith-Lemli-Opitz Syndrome fibroblasts reveal the importance of endogenous cholesterol biosynthesis to the innate immune response
Meclizine inhibits mitochondrial respiration through direct targeting of cytosolic
We recently identified meclizine, an over-the-counter anti-nausea drug, as an inhibitor of mitochondrial respiration. Curiously, meclizine attenuated respiration in intact cells but not in isolated mitochondria, suggesting an unorthodox mechanism. Using a metabolic profiling approach, we now show that treatment with meclizine leads to a sharp elevation of cellular phosphoethanolamine, an intermediate in the ethanolamine branch of the Kennedy pathway of phosphatidylethanolamine biosynthesis. Metabolic labeling and in vitro enzyme assays confirmed direct inhibition of the cytosolic enzyme CTP:phosphoethanolamine cytidylyltransferase (PCYT2). Inhibition of PCYT2 by meclizine led to rapid accumulation of its substrate, phosphoethanolamine, which is itself an inhibitor of mitochondrial respiration. Our work identifies the first pharmacologic inhibitor of the Kennedy pathway, demonstrates that its biosynthetic intermediate is an endogenous inhibitor of respiration, and provides key mechanistic insights that may facilitate repurposing meclizine for disorders of energy metabolism.
Novel mechanism for brain prostanoid level regulation through bile acid receptors
Stephan A. Brose, Kendra L. Puig, Svetlana A. Golovko, Colin K. Combs, Mikhail Y. Golovko Department of Basic Sciences, University of North Dakota, Grand Forks, ND.
To develop an alternative strategy to specifically down-regulate prostanoid (PG) levels upon inflammatory conditions without affecting basal levels in brain cells to avoid multiple side effects of NSAID, we addressed the role for bile acid (BA) receptors in PG and proinflammatory cytokine level regulation in primary brain astrocytes and microglia. BA receptor ligands did not affect PG production under basal conditions in brain primary astrocytes in a wide range of bile acids concentrations. However, upon stimulation with LPS or β-amyloid, they dramatically decreased PGE 2 , PGD 2 , and 6keto-PGF 1 levels to basal levels when physiologically relevant bile acid concentrations were used. Consistent with these results, BA also decreased proinflammatory cytokine levels in microglia and astrocytes upon stimulation, including TNF and IL6. Importantly, the viability of brain primary astrocytes, microglia, and neurons was not affected by BA treatment. The evaluation of BA receptor signaling pathways revealed an important role of FXR signaling mechanism in both BA effects and BA synthesis regulation in glia cells. Intriguingly, BA levels were altered in both human and mouse AD brains. In summary, our data demonstrate, for the first time, the regulatory role for bile acid receptors in PG regulation upon treatment with AD and infection relevant stimuli without affecting basal PG levels, and highlight a novel approach for PG level regulation. Many ion channels are known to be regulated by specific lipids, such as the important signaling lipid PI(4,5)P2. The TRPV1 ion channel is activated by heat and capsaicin among other stimuli, and is potentiated by PI(4,5)P2. We have recently used calorimetry and electrophysiology to show that this potentiation requires only extremely low mole fractions of PI(4,5)P2 in the plasma membrane cytosolic leaflet. However we also found that PI(4,5)P2 applied to the extracellular side of the plasma membrane inhibits TRPV1 function. Other charged lipids appear to have similar effects of varying magnitude. Curiously, TRPV1 function also depends strongly on the cells in which it is expressed. For instance, ten times more capsaicin, and ten times more PI(4,5)P2, are required to open TRPV1 channels in F11 cells, a hybridoma of rat DRG cells and mouse neuroblastoma, than are required in HEK293T/17 cells. We hypothesize that these observations may result from differences between HEK293T/17 and F11 cells in the total amount of important lipids like PI(4,5)P2, other charged lipids, or even cholesterol in the plasma membrane. Our preliminary evidence suggests HEK293T/17 cells have a higher cholesterol:phospholipid ratio than F11 cells derived from dorsal root ganglia neurons. Alternatively, the observed functional differences may result from different transbilayer distribution of lipids in the plasma membrane, since we have shown that charged lipids in the extracellular leaflet inhibit TRPV1 function. Differences in post-translational modification of TRPV1 or in its interactions with other proteins could contribute to functional differences as well. We will outline our results characterizing the lipids of HEK293T/17 and F11 cells, and discuss our approach to future studies of lipid regulation of TRPV1. The peroxisome proliferator-activated receptors (PPARs) are ligand activated nuclear receptors that regulate cellular homeostasis and metabolism. PPARs control the expression of genes involved in lipid metabolism and have emerged as potential targets for the treatment of a number of diseases mainly dyslipidaemias. However, PPAR ligands are associated with a variety of adverse pathological changes, including the induction of various cancers and skeletal muscle wasting, which have overshadowed their development as therapeutics. Given the important role of PPAR agonists in lipid metabolism, a metabolomic approach was used to investigate the effects of dietary treatment of male Sprague-Dawley rats with the PPAR-pan agonist GW625019 in order to develop a model of the liver pathophysiology associated with this agonist. The compound was administered by daily oral gavage at 30,100, 300, 1000 mg/kg/day for 13 weeks. A satellite group of animals were kept for a further 4 week treatment free period. The PPAR-pan agonist increased total phospholipid and decreased triacylglycerol (TG) concentrations. Acylcarnitine concentrations also increased including free-and acetylcarnitine as well as stearoyl-, oleyl-, linoleyl-and palmitoyl-carnitines. The inverse correlation between the TGs and acylcarnitines reflect increased β-oxidation induced by the agonist treatment. The agonist caused an increase in the production of reactive oxygen species (ROS) such as oxomethionine, methyl cytosine and adenosyl methionine, associated with inflammation and DNA damage. Changes in the concentration of several eicosanoids were also increased in concentration including cyclooxygenase products, prostaglandins (PGs) 15d-PJG2 and PGB2. The effects observed in the present study were reversible indicating an adaptive rather than an adverse response. In summary, the results of clinical chemistry were in good agreement with high throughput metabolic profiling where increased liver weights correlated with mode of action specific effects associated with energy storage (TGs and acylcarnitines), cell and/or organelle proliferation (phospholipids) and inflammation (eicosanoids and ROS).
PPAR-pan induced metabolic changes in the liver
Non-alcoholic steatohepatitis (NASH) is a progressive form of NAFLD associated with worsening cirrhosis and hepatocellular carcinoma (HCC). The pathogenic mechanisms underlying such hepatic pathologies remain to be fully elucidated. Improved metabolic characterisation of NASH may uncover diagnostic and prognostic disease markers or identify novel targets for treatment. In this study, a metabolomics approach was utilised to compare a rat model of NAFLD induced by a choline deficient (CD) diet with control animals. In addition rats were treated with a thyroid hormone analogue, GC-1, to assess the potential of this intervention as a therapeutic for NAFLD. A comprehensive metabolomics strategy combining 1 H nuclear magnetic resonance (NMR) spectroscopy, gas chromatography-mass spectrometry (GC-MS), ultra performance liquid chromatography-mass spectrometry (UPLC-MS) and direct infusion mass spectrometry was employed to investigate metabolite changes in the liver. CD diet significantly increased the total fatty acid concentration by increasing medium and long chain fatty acids. Consistent with the fatty acid profile, we observed marked accumulation of acylcarnitine species in the livers of animals on a CD diet which may be attributed to incomplete mitochondrial β-oxidation. Total lipid profiling revealed increased unsaturated (5-8 double bonds) of acyl chains within triacylglycerides (TAG) in the livers from the CD group. This liver tissue was also characterised by increased glycolysis and ketogenesis, and decreased gluconeogenesis. In addition, oxidative stress was increased as measured using the surrogate oxidised methionine. A 2 week co-feeding with GC-1 lowered the total fatty acid content and lipid accumulation in the CD diet livers. There was a dramatic increase in the concentration of betaine in the GC-1 treated liver, a reported lipotrope which may prevent or reduce accumulation of fat in the liver. Furthermore, positive correlations between the increase of betaine and several acylcarnitine species have been found. The use of deuterium incorporation into fatty acids from deuterated water is a well-established method for assessing hepatic de novo lipogenesis (DNL). While it is a robust method, sample preparation is realtively time consuming and requires the subject's body water to be relatively highly enriched. Recent indications from various lipidomic-centred studies have shown that plasma triglycerides (TGs) containing saturated fatty acids of a low carbon number, for example palmitate (-C16:0), are associated with increased risk of insulin resistance (IR) or related disorders and may reflect increased DNL in the liver. Such a lipidomic marker of DNL would have widespread applicability in terms of following the contribution of DNL to IR in human epidemiology studies. To test the hypothesis that palmitate containing TGs are markers of DNL activity, ob/ob mice and wild type controls were fed for two weeks on either a regular chow diet (to allow overfeeding in the ob/ob mice to stimulate DNL) or a high fat diet (to inhibit DNL). Deuterium enriched water was consumed ad libitum for the two weeks to enrich the body water content to contain ~1% deuterated water, prior to an intraperitoneal injection of [U-13C] glucose. Mice were killed and blood plasma collected alongside liver tissue, both snap frozen after collection. Subsequently, the lipidomic and fatty acid profiles have been assessed using high resolution liquid chromatography-mass spectrometry (LC-MS), and gas chromatography-mass spectrometry (GC-MS) .The level of enrichment of the fatty acids with deuterium and 13-carbon isotopes calculated using the LC-MS data, GC-MS data and GC/C/IRMS. This has been performed for the hepatic tissue and blood of the mice and crosscorrelated. The findings from this study are presented here. Wake Forest University, Winston-Salem, NC.
Assessing de novo lipogenesis in ObOb mice using stable isotopes and lipidomics
Nrp-1+Foxp3-CD4 T cells are a novel subset of T lymphocytes that are induced in aorta during atherosclerosis development
Neuropilin 1 (Nrp-1) is a type I transmembrane protein that plays an important role in axonal guidance and angiogenesis through interacting with Semaphorin-3A and vascular endothelial growth factor (VEGF), respectively. Recently, Nrp-1 was found on a subset of regulatory T cells (Treg) that migrated into VEGF producing tumors. Moreover, Nrp-1 + CD4 T cells were protective in a murine model of autoimmune encephalomyelitis, suggesting that these cells may play a role in other inflammatory diseases. Since atherosclerosis is a chronic inflammatory disease where T cells, macrophages, and other immune cells orchestrate disease progression, we hypothesized that Nrp-1 + CD4 T cells are induced in the aorta during atherosclerosis development and play a role during disease progression. We fed ApoE -/-mice a western diet for 15 weeks and found a 2-fold increase in Nrp-1 + Foxp3 -CD4 T cells in the spleens, peri-aortic lymph nodes and aortas of western diet fed mice compared to chow-fed mice. In addition, these Nrp-1 + Foxp3 -CD4 T cells expressed higher levels of the memory marker CD44 and produced more IFNγ when compared to Nrp-1 -CD4 T cells, suggesting that these cells are more activated. Treatment of CD4 T cells with oxidized LDL (OxLDL) caused upregulation of Nrp-1 on CD4 T cells. Using a transwell migration assay, we found that Nrp1 + CD4 T cells had a 2-fold higher migration index towards VEGF 165 than did Nrp1 -CD4 T cells. Similarly, CD4 T cells from ApoE -/-mice fed a western diet, which expressed more Nrp-1, had a higher migration index towards VEGF 165 compared to cells from chow controls. In conclusion, we have identified a novel subset of Nrp-1 + CD4 +
Changes in inositol-containing sphingolipid metabolism regulates stress response signaling
Stephen A. Jesch, Maria L. Gaspar, Susan A. Henry Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY.
The phospholipid precursor inositol exerts profound effects on both the regulation of lipid metabolism and stress response signaling. In the present study, we show that inositol starvation in budding yeast results in a dramatic reorganization of sphingolipid metabolism, most notably the metabolic channeling of phosphatidylinositol into complex, inositol-containing sphingolipids. Following removal of inositol from the growth medium of dividing cells, a new steady-state lipid composition of the three inositol-containing sphingolipid species present in S. cerevisiae was established within 5-6 h. Inositol phosphoceramide (IPC) and mannosyl-di-IPC levels were reduced by 4-fold while mannosyl-IPC levels were elevated by almost 5-fold. To identify lipid-mediated signaling networks that respond to the reprogramming of inositol-sphingolipid metabolism, we carried out gene expression profiling following inositol starvation. These results revealed that genes controlled by three plasma membranelocalized stress response pathways, including PKC-MAPK, HOG signaling and calcineurin pathways, were initially highly up-regulated following inositol removal but were eventually down-regulated after long term inositol starvation. Consistent with these findings, mutants in each pathway exhibited inositol auxotrophy. Moreover, pharmacological inhibition of sphingolipid metabolism constitutively activated protein kinase C, HOG pathway, and calcineurin signaling and stimulated the enrichment of a PI4P biosensor on the plasma membrane.
Together, these results demonstrate that plasma membrane localized inositol sphingolipids control stress response signaling and suggest a feedback mechanism for regulating sphingolipid metabolism. Introduction: Lipids play a key role in cell, tissue and organ physiology and with diseases such as cancer and diabetes which involve disruption of their metabolic enzymes and pathways. Identification of unique lipid biomarkers to distinguish healthy humans compared to those with a disease can have an impact on the early detection of diseases and personalized medicine. In this study, we present the number of lipid species identified in LC-MS experiments can be increased significantly by using optimized HPLC separation and HR/AM (high resolution accurate mass) MS and data-dependent MS 2 conditions. Methods: The whole lipid extract from Bovine liver (Avanti Polar Lipids) was separated via a 2.1 x 100 mm Ascentis C18 column using several different HPLC methods. Eluting compounds were detected in a bench-top quadrupole Orbitrap mass spectrometer (Q Exactive, Thermo Scientific) in data-dependant MS 2 acquisition mode under both positive and negative electrospray ionization conditions. Different Orbitrap resolutions (17.5K, 35K, 70K & 140K) were used. Acquired data were processed and compared using LipidSearch software (Thermo Scientific). Preliminary Results: For initial RPLC experiments, a 2.1 x 100 mm Ascentis C18 column was employed. Several gradient conditions were used to evaluate the separation efficiency. LipidSearch software was used for lipid identification through a database search of the accurate masses of precursors and the fragment ions predicted for each potential adduct form of the lipids in the database (> 1,500,000 entries). The number of lipid species identified in each different experiment were assessed at the sum composition (MS) and isomer (MS-MS) levels. The higher MS resolution enabled higher lipid identification coverage. Background: Rheumatoid arthritis (RA) is an inflammatory disease of the joint characterized by chronic synovitis causing pain, swelling and loss of function due to destruction of cartilage and bone. The complex series of pathological events occurring in RA is largely regulated via excessive production of pro-inflammatory cytokines, the most prominent being tumor necrosis factor (TNF). TNF is a potent inducer of synoviocyte cPLA2 1 . Objectives: Determine if cPLA2 inhibitors AVX001 and AVX002 2 reduce parameters of arthritis progression and severity in prophylactic and therapeutic models of collagen-induced arthritis (CIA) in male DBA/1 mice. Methods: In the prophylactic study, treatment with AVX001 and AVX002 started one hour before the second challenge of type II collagen. In the therapeutic study, treatment started 7 days after the second collagen challenge. Methotrexate (MTX) and Enbrel were included as anti-rheumatic drug controls in the prophylactic and therapeutic studies, respectively. DMSO was included as vehicle control. Intraperitoneal injections of AVX001 and AVX002 were given daily for the first 4 days and then every second day, while MTX and Enbrel were administered daily and twice weekly, respectively. Disease activity and the effects of treatment were monitored by determining arthritis index (paw swelling), recording of histopathological scores and by measuring plasma level of PGE2. Results: Arthritis was evident in collagen-treated animals, and disease severity was significantly reduced with Enbrel or MTX treatment (reduction of AI by 42 % and 38 %, respectively). Treatment with cPLA2 inhibitors AVX001/2 significantly reduced AI by 54% in the prophylactic model and by 60% in the therapeutic model. Several parameters of joint damage were significantly reduced by between 75-90% in response to AVX001/2 treatment as evaluated by histopathology; articular cavity inflammatory cell infiltration, synovial hyperplasia, articular cartilage damage, and periosteal/endochondral ossification compared to ctr. mice, suggesting disease modifying properties of AVX compounds. The plasma PGE2 level was also sign. reduced. Conclusion: The cPLA2 inhibitors AVX001 and AVX002 significantly and potently improved the clinical course of arthritis and reduced the production of inflammatory and analgesic PGE2 in murine CIA. These data suggest that cPLA2 inhibitors, such as AVX001 and AVX002, are potent DMARDs and have the potential to be developed as novel, specific, small molecule, anti-rheumatic human therapeutics. The liver plays a central role in glucose homeostasis and metabolism of lipids and amino acids. A chronic lipid oversupply of the liver is accompanied by excess lipid deposition called steatosis, an early form of nonalcoholic fatty liver disease (NAFLD). There is close correlation between hepatic steatosis and the development of insulin resistance.Recently, we have shown that palmitate induces an impressive formation of extra-and intracellular sphingosine 1-phosphate (S1P) in primary rat and human hepatocytes. In analogy to palmitate, S1P is able to counteract insulin signaling. Thus, insulin-mediated glucokinase expression as well as Akt-phosphorylation is significantly diminished in the presence of S1P. The inhibitory effect of S1P is receptor-dependent and is abolished in the presence of the S1P 2 -receptor antagonist JTE-013 in vitro. Therefore, we examined the role of S1P 2 -signaling on insulin resistance in a high fat diet (HFD) fed New Zealand Obese (NZO) mice model. As expected, there was a drastic increase of blood glucose levels in HFD-compared to standard diet (SD)-fed mice over a time period of 4 weeks. Most interestingly, after treatment of HFD-fed mice with JTE-013 glucose levels did not further increase compared to vehicle-treated HFD-fed mice. To proof whether JTE-013 mediates this action via improvement of hepatic insulin resistance, Akt-phosphorylation in the liver was measured after insulin injection. Indeed, Akt-phosphorylation was significantly decreased in HFD-compared to SD-fed mice. Treatment Our recent genome-wide association studies (GWAS) have identified N-acetyltransferase 2 (NAT2) as a new candidate gene for insulin resistance. NAT2 encodes a xenobiotic metabolizing enzyme which catalyses biotransformation of various drugs and carcinogens. The aim of this study was to evaluate the role of NAT2 and its association with the development of insulin resistance. In this study, we demonstrated that silencing of Nat1 (the mouse homolog to NAT2) in differentiated 3T3-L1 adipocytes resulted in increased basal and isoproterenolstimulated lipolysis and reduced insulin-stimulated glucose uptake. In addition Nat1 knockdown significantly decreased the expression of adipogenic marker genes and adipocyte differentiation. Furthermore, Nat1 silencing led to increased production of intracellular of reactive oxygen species (ROS), decreased mitochondrial membrane potential, mitochondrial biogenesis and mitochondrial content in 3T3-L1 adipocytes. Collectively, our results suggest that Nat1 knockdown increased lipolysis and mitochondrial dysfunction in adipocytes, which might be responsible for the development of insulin resistance.
Increased lipid identification coverage for global lipidomics analyses using a benchtop quadrupole-Orbitrap LC-MS/MS system
Novel inhibitors of cytosolic
Nat1 ablation contributes to increased lipolysis and mitochondrial impairment in 3T3-L1 adipocytes
Microfluidics lipidomics using a novel integrated mass spectrometry technology
Giuseppe Astarita, Angela Doneanu, Jay Johnson, Jim Murphy, Robert Plumb, James Langridge Waters Corporation, Milford, MA.
Lipidomics heavily relies on the development of new technologies for the comprehensive analysis of hundreds of lipid species in biological samples. The ability to measure the wide array of lipid species in biological samples could help our understanding of their roles in health and disease. The need for a fast, comprehensive and sensitive analysis of the hundreds of lipid species challenges both the chromatographic separation and mass spectrometry. Here we used a novel integrated microfluidics-mass spectrometry technology packed with C18 1.7 µm particles for fast and robust targeted lipid analysis. By integrating microscale LC components into a single platform design, the device avoids problems associated with capillary connections, including manual variability, leaks, and excessive dead volume. Mobile phases and analysis times were similar to regular LC methods using analytical-scale columns. Data was collected using MS systems (Q-Tof and triple quadrupoles) operated in both negative and positive mode in the data independent acquisition mode. Lipidomics analyses were conducted using small volumes of standards and organic extracts from typical biological samples including plasma, brain, heart and liver.We identified and quantified 215 lipid species belonging to various lipid classes including phosphatidylethanolamines (PE), lyso PE, phosphatidylcholines (PC), lyso PC, ceramides (Cer), sphingomyelins, hexosylceramides, lactosylceramides and cholesterol esters. Lipids were measured over approximately five orders of dynamic range. Lipids were separated according to acyl chain length and number of double bonds. The small column diameter (150 m) of the microfluidic device allowed low injection volumes (0.2-0.5 l) and low flow rates (2-5 l/min) increasing up to 10x the sensitivity compared to regular analytical columns (e.g., 2.1 mm ID). Mobile phase consumption was reduced about 200X compared to 2.1 mm ID chromatography albeit maintaining comparable chromatographic resolution and analysis times. Potential applications include large-scale lipid profiling and low-abundance lipid analyses in biological materials.
Protection against fatty acid-induced lipotoxicity: modeled microgravity as a tool for the identification of novel pathways
Magda Latorre-Esteves Chemical Engineering Department, University of Puerto Rico-Mayagüez Campus. Mayagüez, Puerto Rico.
The NIH National Heart, Lung and Blood Institute defines the "metabolic syndrome" as a group of risk factors associated with an elevated risk for insulin resistance, diabetes and coronary heart disease. These diseases are projected to cost $48-66 billion/year in the USA by 2030. Metabolic syndrome is directly linked to an excess of free fatty acids in non-adipose tissues, such as pancreas, heart, and skeletal muscle. When these free fatty acids (FFAs) overwhelm the cell, it results in the formation of reactive lipid species that promote cellular dysfunction (lipotoxicity) and programmed cell-death (lipoapoptosis). One mechanism by which the cell handles excess FFAs is through their acylation, which leads to the formation of neutral lipids that can be stored in lipid droplets (LDs). Long considered to be central to the pathogenesis of metabolic diseases, there is now evidence that LDs can protect against lipotoxicity.Microgravity can be achieved during spaceflight or other modeled conditions, significantly alters numerous biological processes in organisms from bacteria to humans. This led us to observe that in microgravity conditions, cells and organisms naturally adapt to this environment by increasing LD generation. We have analyzed the expression of 113 genes associated with lipid droplet morphology under the Gene Ontology (GO) term "lipid particle morphology" in the Saccharomyces Genome Database Gene Ontology Database. Using microarray data obtained from yeast cells grown in modeled microgravity from the Gene Expression Omnibus (NIH) we confirmed that 26% of genes associated with "lipid particle morphology" show more than a 1.5 fold change in expression compared to cells grown in normal gravity.We hypothesize that enhancement of LD formation can be used as a mechanism of protection against FFA-induced lipotoxicity. We will explore this hypothesis by elucidating the molecular events that lead to increased LD formation in microgravity conditions. If these as yet unexplored mechanisms can be molecularly recreated in normal gravity conditions, we can potentially identify of pathways that can be used to create targets for the management FFAinduced lipotoxicity. Atherosclerosis is a chronic inflammatory disease initiated with monocyte recruitment into the vessel wall. Ox-PAPC (oxidized 1-palmitoyl-2-arachidonyl-sn-glycerol-3-phosphorylcholine) was identified as bioactive component of minimally modified low-density lipoprotein (MM-LDL) that accumulates in subendothelial space under hyperlipidemic condition. Ox-PAPC strongly activates vascular endothelial cells and regulates more than 1,500 genes including proinflammatory and prothrombotic genes IL-8, MCP1, and tissue factor (F3). Bromodomain and extraterminal (BET) family is a reader for histone acetylation signals written by endogenous and exogenous proinflammatory agents. Highly specific and potent BET inhibitors recently developed showed strong repression of inflammatory responses both in vitro and in vivo systems. In this study we tested whether BET family is a mediator for the inflammatory signals induced by Ox-PAPC in the vascular endothelial cells. First, in human aortic endothelial cells (HAECs) the BET inhibitors (JQ1(+) and negative control JQ1(-), I-BET, I-BET151) and siRNA targeting a member of BET family BRD4 showed vary potent inhibition of inflammation related gene expressions by Ox-PAPC. Next, we expanded this study to microarray analysis to obtain the full list of Ox-PAPC regulated genes inhibited by BET inhibitor JQ1(+) cotreatment. The gene list showed significant enrichment of genes in categories of inflammation, apoptosis, and cell death as determined by gene ontology (GO) and KEGG pathway analysis. In comparison of the role of BET family on Ox-PAPC versus LPS we found significant overlapping. In conclusion, in this study we showed that BET family, which is a reader of the histone acetylation, is a key mediator for the inflammatory responses induced by Ox-PAPC in the vascular endothelial cells with selectivity. Targeting of BET family could be an efficient approach to specifically modulate atherosclerosis and the other inflammatory vessel diseases correlated with hyperlipidemia. Growing evidence suggests that specific plasma fatty acid (FA) pattern may be indicative of insulin resistance (IR) as saturated, trans and omega (n)-3/n-6 FAs ratio enhance inflammation. However, the role FA composition of important metabolic tissues have not the focus of most of the investigations. Objective: To establish whether (i) IR is associated with FA composition in the intestine, liver and adipose tissue of obese subjects; (ii) the FA changes in tissues are related to those observed in plasma; and (iii) FA profile is related to specific desaturases. Methods: Duodenal, hepatic and fat specimens were obtained from 18 obese subjects undergoing bariatric surgery with either low or high IR. Plasma and tissue FA compositions were measured using gas chromatography following total lipid esterification. Results: Plasma of insulin-resistant subjects was mainly characterized by an increased amount of total FA, a higher proportion of saturated FA and a lower proportion of polyunsaturated FA. Similarly, we observed an increased amount of total FA in duodenum and liver of insulinresistant subjects as compared to insulin-sensitive subjects. These increases were mainly explained by higher levels of saturated FA. The proportion of polyunsaturated FA, especially n-3, was reduced in liver and in subcutaneous adipose tissue, but not in duodenum, of insulin-resistant subjects. Importantly, eicosapentaenoic (EPA) and docosahexaenoic (DHA) as well as the n-3 to n-6 ratios were positively associated with IR in the liver but not in the plasma and other tissues. Finally, we noticed that the estimated delta 9-desaturase activity (product/precursor ratio) was increased only in the liver of insulin-resistant subjects. Conclusion: Several alterations in plasma and tissue FA composition were present in obese subjects with IR, but many disparities between tissues were noted. Plasma and hepatic saturated FA as well as hepatic n-3 FA were significant correlates of the Ir state in human.
Bromodomain and extraterminal (BET) family is a key mediator for
Effect of insulin resistance on plasma and tissue fatty acid profile in severely obese subjects
The effects of ozone therapy on serum neopterin level and necrosis in a rat model of acetaminophen induced liver injury
Husamettin Gul, Bulent Uysal, Erdinc Cakir, Halil Yaman, Enis Macit, Ali Osman Yildirim, Yusuf Emrah Eyi, Umit Kaldirim, Emin Aktas, Emin Ozgur Akgul, Tuncer Cayci, Mehmet Ozler, Turgut Topal, Sukru Oter, Ahmet Korkmaz, Mehmet Toygar, Suzi Demirbag Dept of Toxicology, Gulhane Military Medical Academy, Ankara, Turkey. Acetaminophen (APAP) is a widely used agent for its analgesic and antipyretic actions. Therapeutic dose of APAP is considered to be safe while its overdoses produce severe centrilobular liver injury that can lead to fatal fulminant hepatic failure. Elevated serum alanine aminotrasferase and aspartate aminotrasferase activities indicate liver damage. Although the elevated activities of these enzymes are indicators of hepatocellular damage, they are poor prognostic indicators for the severity of the liver injury or acute liver failure. It was shown that serum neopterin, a marker for immune system activation, levels were elevated in a rat model of acetaminophen induced liver injury. Increased neopterin levels were correlated with the dose of acetaminophen. Ozone therapy (OT) is shown to reduce inflammation and necrosis in several entities. This study is designed to evaluate the efficacy of ozone therapy in a rat model of APAP-induced liver injury. Serum neopterin levels were measured with HPLC-FD device. Phosphate buffer (0.015 M, pH 6.4) was used as mobile phase (isocratic elution) at a flow rate of 0.8 ml/min. APAP administration caused necrosis in the liver after 24 h. In the APAP group, serum neopterin concentrations (14.7±1.4 nmol/L) were significantly increased compared to other groups (in both, p<0.05). OT administration reduced both necrosis and neopterin levels significantly (7.5±2.4 nmol/L) (p<0.05) but still higher than the sham group (4.8±1.2 nmol/L) (p<0.05). Our results showed that ozone therapy prevented liver necrosis in rats and reduced neopterin levels. These findings suggest that the use of OT as an adjuvant therapy which might improve the outcome in APAP induced liver injury.
Lipid mediators play an important role in reproductive biology, especially, in parturition. Enhanced biosynthesis of eicosanoids such as prostaglandin E 2 (PGE 2 ) and prostaglandin F 2 (PGF 2 ), precedes the onset of labor as a result of increased expression of the inducible cyclooxygenase (COX-2) in placental tissues. Metabolism of arachidonic acid results in bioactive lipid mediators beyond prostaglandins that could significantly influence myometrial activity. Therefore, an unbiased lipidomic approach was used to profile the arachidonic acid metabolome of amniotic fluid. Using liquid chromatography -mass spectrometry methods, this study, for the first time, quantitatively enumerates these metabolites in human amniotic fluid by comparing patients at 1) mid trimester , 2) term but not in labor, and 3) term in spontaneous labor. In addition to exposing novel aspects of cyclooxygenase pathway metabolism, this lipidomic study revealed a dramatic increase of epoxygenase and lipoxygenase pathway derived lipid mediators in spontaneous labor with remarkable product selectivity. Despite their recognition as anti-inflammatory lipid mediators and regulators of ion channels, little is known about the epoxygenase pathway in labor. Epoxygenase pathway metabolites are established regulators of vascular homeostasis in cardiovascular and renal physiology. Their presence as the dominant lipid mediators at term in spontaneous labor portends a yet undiscovered physiological function in parturition.
Lipidomics by infusion-based MS/MSALL reveals novel aspects of fatty liver disease
Jeffrey McDonald
UT Southwestern Medical Center, Dallas, TX.
Lipidomics is a new and expanding field of research driven in part through advances in analytical measurements made by the LIPID MAPS Consortium. The mammalian lipidome is complex, requiring dedicated analytical techniques to measure each lipid class. This presents a challenge to researchers as few laboratories have the resources or capability to perform such analyses. Infusion-based MS/MS ALL is a novel mass spectrometry technique that yields comprehensive measurement of the lipidome in a single analysis. During infusion of a bulk lipid extract (Bligh-Dyer extraction) a high resolution TOF spectrum is acquired followed by a product-ion spectrum at each unit mass (150-1200 Da). This produces a complete lipidomic mass spectral dataset that can be interrogated post-acquisition for any lipid class or lipid feature using neutral loss and product/precursor-ion relationships. Recent work has identified Ezetimibe as a possible therapeutic target for FLD, but only global changes in cholesterol and triglycerides were described. Here we present lipidomic analysis of mouse models for FLD during treatment with Ezetimibe. Using MS/MS ALL workflows, we measured glycerolipids, cholesterol, cholesteryl esters, and profiled the entire lipidome in mouse liver and plasma during treatment with Ezetimibe. Initially, over 300 lipids were identified from all major classes by querying the dataset with a combination of neutral loss, precursor ion, and fragment ion analysis. Unique changes in several lipid species were identified relative to diet and treatment in both fatty acid composition and degree of saturation. Utilization of a second targeted extraction procedure for the isolation of neutral lipids resulted in the identification of sterols esterified with oxidized fatty acids. Oxidized fatty acids were also observed in glycerolipids. Additionally, we were able to identify steryl esters originating from biosynthetic precursors of cholesterol, oxysterols, and plant sterols. Supercritical fluids possess density and extraction ability similar to liquid, but diffusivities similar to gas, which allows high-speed separation of complex biological mixtures. Ion mobility spectrometry rapidly separates ions (on the scale of milliseconds) based on their three-dimensional structures in the gas phase (ion-neutral collision cross section; Ω). When ion mobility is coupled with mass spectrometry, a two-dimensional separation is achieved on the basis of the charge-to-collision cross section (z/Ω) and the mass-to-charge (m/z), respectively. Here we report the first integration of supercritical fluid chromatography (SFC; ACQUITY UPC 2 , Waters Corp.) with ion mobility-mass spectrometry (IM-MS; Synapt G2-S HDMS, Waters Corp.) and its application in studying the lipidome of mouse brains. Lipid extracts of mouse brains (3-week old) were re-constituted in chloroform and were subjected to SFC-IM-MS analysis in both positive and negative ion mode. The mobile phase used is a gradient of supercritical CO 2 and methanol (with 0.1% ammonium formate). Under the optimal SFC condition, separation of over 10 classes of lipids was achieved within 10 minutes. We found that ion mobility separation is particularly useful in removing the chemical noise MS signals from the desired lipid signals, which significantly improved the signal-to-noise ratios of the chromatographic peaks. The identified lipids include sub-classes of phospholipids, sphingolipids, and sterols. In the positive ion mode, post-mobility fragmentation provides the head-group information to confirm the lipid classes. In the negative ion mode, fragmentation provides information on the fatty acids composition of each class of lipids. Thus, we present a rapid lipidomics strategy that combines the chromatographic advantage of SFC and the structural separation advantage of ion mobility. LIQUID (Lipid Informed Quantitation and Identification) is a software program that has been developed to enable users to conduct both informed and high-throughput global liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based lipidomics analysis. This newly designed desktop application can quickly identify and quantify lipids from LC-MS/MS datasets while providing a friendly graphical user interface for users to fully explore the data. Informed data analysis simply involves the user specifying an electrospray ionization mode, lipid common name (i.e. PE(16:0/18:2)), and associated charge carrier. The software searches the loaded dataset for evidence of the specified lipid and returns the highest scored matches and associated evidence for the user to view. For global analysis of an entire dataset, the user must load in a set of lipid targets. The software iterates over each MS/MS spectrum in the loaded dataset to find the best lipid match(es) for each. For both informed and global analysis, the software allows the user to select a result in the output table, which triggers a graphical display of all observed and theoretical lines of evidence used for identification. The primary evidence shown is a stem plot of the MS/MS spectra including colors and labels for peaks that match to fragments of the identified lipid. A stem plot of the isotopic profile and a line plot of the extracted ion chromatogram are also provided to show the MS-level evidence of the identified lipid. In addition to plots, other information such as intensity, mass measurement error, and elution time are also provided. Typically, a global analysis for 15,000 lipid targets is executed in less than 5 seconds and evidence of each lipid is immediately displayed to the user.
Lipidomic analysis of mouse brain using supercritical fluid chromatography-ion mobility-mass spectrometry
LIQUID: Lipid Informed Quantitation and Identification
Dietary 1-deoxy-sphingolipids: a new concept in the dietary impact of sphingolipids
Jingjing Duan, Alfred H. Merrill, Jr.
School of Biology and the Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA.
Sphingolipids have been classically defined as having sphingoid base backbones that are 1, 3-dihydroxy, 2-amino-alkanes and -alkenes; however, humans and other organisms also produce sphingoid bases without the 1-hydroxyl group (Merrill, A.H., Jr. Chem Rev 111, 6387-422, 2011) . These are very interesting structural variants because such compounds have been found in screens of aquatic organisms for anti-cancer agents, and one (1-deoxysphinganine, a.k.a. "spisulosine" and "ES-285," from the arctic surf clam Spisula polynyma) has undergone human phase I clinical trials (Vilar, E. et al. Invest New Drugs 30, 299-305, 2012) ; likewise, a synthetic sphingoid base analog (Enigmol) that lacks the 1-hydroxyl-group has anti-tumor efficacy for colon and prostate cancer in animal models (Symolon, H. et al. Mol Cancer Ther 10, 648-57, 2011 ). However, 1-deoxysphingoid bases have also been associated with inherited peripheral neuropathies (Penno, A. et al. J Biol Chem 285, 11178-87, 2010; Murphy, S.M. et al. Neurology 80, 2106 -11, 2013 , so their occurrence and effect(s) on health still need to be determined. To aid in their analysis, we have developed methods for identification and quantitation of 1-deoxy-sphingoid bases and their N-acyl metabolites using liquid chromatography, electrospray ionization tandem mass spectrometry and have begun to survey their occurrence in cells, tissues, and food as well as factors that influence their metabolism. These methods and our findings from analysis of selected foods, as well as studies of the uptake and metabolites of 1-deoxy-sphingoid bases and a 1-deoxy-sphingolipid analog (1-deoxy-1-fluoro-sphingosine) will be shown. Apolipoprotein A-I Binding Protein (AIBP) is a conserved protein that is found in the mitochondria, cytoplasm, and nucleus, in addition to being secreted. Our laboratory recently demonstrated that extracellular AIBPmediated cholesterol efflux controls angiogenesis in zebrafish. While secreted AIBP has been shown to regulate cholesterol efflux, little is known about its intracellular functions. To investigate these, our laboratory has generated Aibp -/-mice, which are viable and fertile. A recent paper suggests that AIBP is an NAD(P)H-hydrate epimerase, giving it a presumptive role in mammalian NAD+ homeostasis. We hypothesized that by maintaining an appropriate cellular NAD+ level, AIBP indirectly regulates SIRT1, an NAD+-dependent histone deacetylase with targets including inflammatory and metabolic regulators such as NF-κB, AP-1, and Akt. SIRT1 expression and function were decreased in Aibp -/-mice, as determined by Sirt1 mRNA transcript levels and acetylation status of SIRT1 targets. The presumptive role of AIBP in NAD+ homeostasis indicates a link between energetic status and AIBP activity, suggesting that metabolic disturbances should exacerbate the effects of Aibp knockout. Indeed, Aibp -/-mice fed a 45% high-fat diet (HFD) gained significantly more weight than wild type mice, despite consuming a similar quantity of food. In contrast, chow-fed knockout mice did not weigh more than their wild type counterparts. On the HFD, knockout mice also had decreased VO2 consumption and VCO2 production, but did not exhibit differences in heat production or respiratory exchange ratio. HFD-fed Aibp -/-mice were also glucose intolerant and had increased M1 pro-inflammatory macrophage infiltration in their white adipose tissue, indicating the development of metabolic syndrome. A better understanding of AIBP's regulation of inflammation and metabolism will provide new mechanistic insights and therapeutic targets for metabolic disorders. Preeclampsia (PET) is linked to obesity and increased adipocyte lipolysis, and is a leading cause of pregnancyrelated morbidity. Women with PET have reduced high-density lipoprotein (HDL) levels and increased plasma triacylglycerol (TG), low-density lipoprotein (LDL) and non-esterified fatty acid levels compared to healthy pregnancy. In women with PET their maternal erythrocytes and fetal cord blood have lower polyunsaturated fatty acid (PUFA) levels compared to healthy controls, suggesting a reduced supply of PUFA in the fetal circulation. To investigate changes in lipid metabolism in PET, we quantified apolipoprotein B (apoB), TG and total cholesterol (TC) in maternal very low-density lipoprotein (VLDL) isolated from plasma of PET and control subjects. Fatty acids (FA) extracted from VLDL particles were quantified by gas chromatography (GC). Quantitative lipidomics was performed on placental samples. Lipids were extracted from placental tissue and analyzed using an AB Sciex QTRAP 5500 with an Advion Nanomate nano-electrospray source. Targeted precursor-ion and neutral-loss scans were used to identify and quantify approximately 120 lipid species. Maternal VLDL apoB and therefore VLDL particle number was doubled in PET compared to controls. TG and TC levels were also substantially higher in PET patients. However, TG and TC levels per VLDL particle were unchanged. This suggests the maternal system increases VLDL synthesis in PET, but the composition is unchanged. This was supported by VLDL FA quantification, which showed unchanged FA levels per particle. In placental tissue, quantification of seven lipid classes, including cholesteryl ester, free cholesterol, TG, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin was performed. Preliminary analysis indicates higher total lipid levels in PET placenta compared to controls. This included a build-up of storage lipids, i.e. TG and cholesteryl ester, as well as increased phosphatidylcholine. Further data will be presented using principal component analysis to elucidate lipid species that contribute to variations between PET and controls. Oxidative stress is thought to contribute to etiology of a broad range of diseases (e.g., cardiovascular, neurodegenerative, immune, etc.). A critical step in its development is lipid peroxidation, initiated by hydrogen abstraction at bis-allylic sites of polyunsaturated fatty acyls (PUFA); this sets in motion a chain reaction that generates multiple toxic products. Synthetic PUFAs with hydrogens at the bis-allylic carbons replaced with deuterium (d-PUFAs) inhibit the chain process. Kinetic isotopic effect that slows down the abstraction step is assumed to be primarily responsible for this inhibition.
Apolipoprotein A-I Binding Protein deficiency promotes development of high-fat diet-induced metabolic syndrome
Alterations of lipid metabolism in preeclampsia: lipid characterization in the maternal circulation and placenta
Protection of mitochondrial function in mammalian cells by deuterated polyunsaturated fatty acids
These mechanisms are of particular relevance to mitochondria, which are both a major source and one of the primary targets of oxidative stress. Therefore we tested protection of bioenergetic mitochondrial function by dPUFAs. Bioenergetic status of intact cells was assayed using high content, high throughput, non-invasive extracellular flux analysis technique (Seahorse Biosciences). Triggers of oxidative stress with various modes of action (i.e., tert-butylhydroperoxide, ethacrynic acid and iron (II)) damage both mitochondrial membrane integrity and respiratory capacity. This damage can be almost completely prevented by incorporation into the cells of dPUFAs with completely deuterated bis-allylic positions; deuteration of non-bis-allylic positions is ineffective. Paradoxally, partially deuterated linoleic acid that still carries one hydrogen atom at the bis-allylic position is also protective. Similarly, incorporation of PUFA mixtures in which just 20-50% are deuterated (fully or partially) are protective. The extent of this protection by partial bis-allylic deuteration is much greater that could be explained by "dilution" effect. These results suggest an existence of a secondary protective mechanism(s) additional to inhibition of abstraction off the bis-allylic sites.
Identification of oxidized phospholipids in bronchoalveolar lavage fluid exposed to ozone
Ann-Charlotte Almstrand, Robert C. Murphy Department of Pharmacology, University of Colorado Denver, Aurora, CO.
Ozone is a powerful oxidant and a common pollutant known to cause adverse respiratory effects. Chemical reactions with unsaturated phospholipids in the respiratory tract lining fluid have been identified as one of the first important steps in the mechanisms mediating ozone toxicity. Thus, an essential part in understanding ozone toxicity is the identification of lipid ozonation products that derive from reactions of ozone with the phospholipid pool. In this study, we exposed human bronchoalveolar lavage (BAL) to low levels of ozone (60, 150 and 300 ppb) for 60 minutes. Ozonized BAL samples with and without derivatization were analyzed by liquid chromatography electrospray ionization tandem mass spectrometry in the full scan (positive and negative mode), precursor ion scan (m/z 184) and neutral loss mode (m/z 172). Data processing, including the selection of variables (peak labels containing m/z and retention time) unique for ozonized and derivatized samples, respectively, was accomplished using principal component analysis (PCA). Resulting PCA score plots showed a linear dose-dependent increase, with apparent changes in BAL samples exposed to as low as 60 ppb ozone compared to non-exposed BAL samples, and a clear separation between ozonized samples before and after derivatization. Corresponding loadings plots showed that more than 30 glycerophosphocholine species decreased due to ozonation and a total of 16 glycerophosphocholine and 5 glycerophosphoglycerol oxidation products were formed with the major part being identified as chain-shortened aldehyde products. The most abundant oxidation products included 1-palmitoyl-2-(9'-oxo-nonaoyl)-glycerophosphocholine and 1-palmitoyl-2-(9'-oxo-nonaoyl)-glycerophosphoglycerol. Hopanoids are lipid molecules of the isoprenoid family found in some bacteria. They play a role similar to cholesterols from eukaryotes in helping cells to deal with environmental stresses such as high temperature, pH variations, and the presence of detergents or antibiotics. Furthermore, potential applications for hopanoids as biomarkers have been proposed because their carbon skeletons are well preserved in fossils dated back to at least 1.7 billion years ago. To better understand the biological roles of hopanoids and better interpret microbial footprints from ancient fossil records, a robust method to quantify hopanoids and identify their localization in bacterial membranes is needed. Here we present the application of LC-MS/MS and GC-MS techniques for the identification and quantification of lipids in cell membranes from two organisms, Burkholderia multivorans and Rhodopseudomonas palustris TIE-1. Clinical isolates of B. multivorans from cystic fibrosis (CF) patients were treated with 256 g/mL fosmidomycin, an antibiotic that targets the non-mevalonate pathway of isoprenoid synthesis, which is required for hopanoid biosynthesis. The treated cells showed up to 49% hopanoid decrease and a 64-fold decrease of the minimum inhibitory concentration of a membrane-disrupting antimicrobial agent, colistin, to as low as 8 g/mL. This suggests blocking hopanoid biosynthesis could make colistin treatment of CF lung infections more effective. In addition, we isolated membranes from a model organism for hopanoid studies, R. palustris TIE-1. Extended (C 35 ) hopanoids such as bacteriohopanetetrol have different distributions between inner and outer membranes compared to short hopanoids (C 30 ) such as diplopterol. The application of robust lipidomic analyses to the study of hopanoids in diverse bacteria will improve our understanding of these molecules in both clinical and environmental contexts. The characteristic carbon rings of hopanoid lipids are preserved over geological times and can be detected as molecular fossils in sedimentary rocks. Bacterial hopanoids are ancestral forms of cyclic triterpenoids and in vitro behave similar to sterols, yet their physiological functions remain poorly understood. Here we report the lipid composition of the anoxygenic phototroph Rhodopseudomonas palustris TIE-1, a model bacterium for studying hopanoid function. Liquid chromatographytandem mass spectrometry (LC-MS/MS) enabled the simultaneous detection of native hopanoids and other polar lipids, providing insights into the chemical milieu in which hopanoids occur. The deletion of genes for the biosynthesis of hopanoids caused distinct changes in the lipid composition, which were quantified for chemoheterotrophic and photoautotrophic growth conditions. These adaptations rationalize how the bacterium can grow in the absence of hopanoids and more broadly might also shed light on membrane homeostasis in bacterial species that do not utilize hopanoids. Based on this work the potential of lipidomics for the study of microbial communities in environmental samples is discussed.
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